SUVN-502 with Donepezil and Memantine for Moderate Alzheimer's Disease
Language
Undefined
Purpose: To test the experimental drug SUVN-502 as a treatment for moderate Alzheimer's disease in people taking donepezil and memantine.
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: chirschman Source Type: clinical trials